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Abstract
Background: Celiac disease is a T cell mediated-inflammatory enteropathy caused by the ingestion of gluten in genetically
predisposed individuals carrying HLA-DQ2 or HLA-DQ8. The immunogenic gliadin epitopes, containing multiple glutamine
and proline residues, are largely resistant to degradation by gastric and intestinal proteases. Salivary microorganisms
however exhibit glutamine endoprotease activity, discovered towards glutamine- and proline-rich salivary proteins. The aim
was to explore if gliadins can serve as substrates for oral microbial enzymes.
Methodology/Principal Findings: Proteolytic activity in suspended dental plaque was studied towards a) gliadin-derived
paranitroanilide(pNA)-linked synthetic enzyme substrates b) a mixture of natural gliadins and c) synthetic highly
immunogenic gliadin peptides (33-mer of a2-gliadin and 26-mer of c-gliadin). In addition, gliadin zymography was
conducted to obtain the approximate molecular weights and pH activity profiles of the gliadin-degrading oral enzymes and
liquid iso-electric focusing was performed to establish overall enzyme iso-electric points. Plaque bacteria efficiently
hydrolyzed Z-YPQ-pNA, Z-QQP-pNA, Z-PPF-pNA and Z-PFP-pNA, with Z-YPQ-pNA being most rapidly cleaved. Gliadin
immunogenic domains were extensively degraded in the presence of oral bacteria. Gliadin zymography revealed that
prominent enzymes exhibit molecular weights.70 kD and are active over a broad pH range from 3 to 10. Liquid iso-electric
focusing indicated that most gliadin-degrading enzymes are acidic in nature with iso-electric points between 2.5 and 4.0.
Conclusions/Significance: This is the first reported evidence for gluten-degrading microorganisms associated with the
upper gastro-intestinal tract. Such microorganisms may play a hitherto unappreciated role in the digestion of dietary gluten
and thus protection from celiac disease in subjects at risk.
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Introduction
The gastrointestinal (GI) tract consists of distinct but connected
anatomical regions, comprising the oral cavity, the oesophagus,
the stomach, the small and the large intestine[1]. The entire GI
tract is colonized with microorganisms with colonization levels
showing a gradient being lowest in the stomach and increasing in
density toward the proximal and distal ends. The proximal region,
the oral cavity, provides a rich environment for bacterial
colonization as it contains a variety of different habitats and
ecological niches. It harbors over 600 different types of bacteria
belonging to 141 different taxa representing 6 different bacterial
phyla, including the Firmicutes, Actinobacteria, Proteobacteria, Bacter-
oidetes, Fusobacteria and the TM7 phylum [2,3]. The distal GI
microbiome is likewise phylogenetically diverse with members
representing at least 9 different phyla [4,5].
The GI tract is considered a ‘‘super organ’’ with functions
contributed by human as well as bacterial genes [6,7]. Most GI-
colonizing microorganisms live in symbiosis with the host. The
mutually beneficial relationship between the host and its colonizers
is most evident in aspects related to digestion. Complex
carbohydrates that cannot be degraded by the arsenal of human
digestive enzymes can in most cases be hydrolyzed by bacterial
glycosidases. For instance, bacteria belonging to the Bacteroides
genus, turn the non-digestable polysaccharides into small chain
fatty acids that are subsequently metabolized by the host [7].
While the role of GI bacteria in the metabolism of polysaccharides
is being unraveled at the molecular level, the contribution of
microbial enzymes to the digestion of proteins is much less
thoroughly investigated. Ingested proteins are in part degraded by
host proteolytic enzymes such as pepsin, elastase, carboxypepti-
dase, trypsin, and chymotrypsin converting them into oligopep-
tides and single amino acids which can then enter the enterocyte
via selective transporters and be further metabolized or transport-
ed [8]. Evidently, this mechanism is contingent upon the
susceptibility of the substrate proteins to digestion by host
enzymes.
Examples of dietary proteins that are difficult to digest by host
proteolytic enzymes are glutens. Gluten proteins, comprising
gliadins and glutenins, are abundantly contained in dietary
products made of wheat, barley and rye [9]. They are unusual
with respect to their high content of the amino acids proline and
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glutamine, which are largely resistent to cleavage by the major
human GI digestive enzymes. Thus pepsin or trypsin are unable to
cleave the peptide bonds C-terminal to these residues [10]. The
proteolytic resistance of some highly T cell stimulatory gluten-
derived peptides that reach the duodenum, e.g. a 33-mer peptide
from a2-gliadin and a 26-mer peptide from c-gliadin, is
paradigmatic for the inability of the human body to thoroughly
digest gluten, resulting in the destructive immunological responses
in the proximal intestine of patients with celiac disease [11,12,13].
Proteolytic degradation of protease-resistant domains in gluten
appears to require enzymatic cleavage specificities that are not
readily available in the repertoire of mammalian digestive
enzymes. Recent studies have revealed that the oral cavity
contains microorganisms producing endoprotease(s) with cleavage
specificity after a glutamine residue [14]. The activity was found
by analyzing the sequences of salivary peptides that are naturally
present in human whole saliva. The salivary peptidome contains
multiple proline- and glutamine rich peptides derived from human
salivary basic proline-rich proteins that were cleaved after the
Xaa-Pro-Gln tripeptide sequence[14,15,16]. We therefore studied
the structural similarity between gliadins and basic proline-rich
proteins and investigated if gliadins may be substrates for oral
microbial proteases and be degraded into non-immunogenic
peptides. The prospect of natural gluten degrading microorgan-
isms associated with the oral cavity, i.e. the very proximal GI tract,
would open promising new avenues in the quest to develop
strategies to neutralize the deleterious effects of gluten in patients
with celiac disease.
Materials and Methods
Dental plaque and whole saliva collection
Protocols for the collection of human dental plaque and whole
saliva (WS) were approved by the Institutional Review Board at
Boston University. Written informed consent was obtained from
all participating subjects prior to sample collection. Plaque was
obtained from a healthy subject 48 h after cessation of oral
hygiene. The sample was collected from interproximal spaces
using a sterile dental scaler and suspended in saliva ion buffer
containing 50 mM KCl, 1.5 mM potassium phosphate, 1 mM
CaCl2 and 0.1 mM MgCl2, pH 7.0 [14]. The plaque material
was dispersed by pipetting and vortexing and the optical density
(OD) of the resulting suspension was determined spectrophoto-
metrically at 620 nm. Stimulated WS (5 ml) was collected from
eight healthy subjects between 10.00 and 11.00 a.m. at least
1 hour after the last meal. Whole saliva flow was stimulated by
mastication on four square inches of Parafilm (American National
CanTM, Chicago, IL). All samples were kept on ice.
Enzyme activity analysis
Four synthetic analogs, Z-YPQ-pNA, Z-QQP-pNA, Z-PPF-
pNA and Z-PFP-pNA, were chosen as representative gliadin-
derived substrates and chemically synthesized (Anaspec, Fremont,
CA). All substrates were dissolved in 50–75% dimethyl sulfoxide to
20 mM. From this solution, 2 ml was mixed with 200 ml plaque
suspension (OD620 1.2) in saliva ion buffer or with 200 ml trypsin
(final concentration 0.2 mg/ml) in 50 mM ammonium bicarbonate
buffer, pH 8.0. All incubations were carried out in 96-well
microtiter plates. Enzyme activity was determined from the
proteolytic removal of the paranitroanilide group which was
monitored spectrophotometrically at 405 nm. Z-YPQ-pNA, Z-
PPF-pNA and Z-PFP-pNA showed mild precipitation upon
mixing with the plaque suspension in saliva ion buffer which did
not interfere with efficient substrate hydrolysis. All values were
corrected for the lowest absorbance values measured after addition
of the enzyme source to the substrate.
Degradation of gliadin and gliadin peptides
A mixture of gliadins was purchased from Sigma (St. Louis,
MO) and dissolved to 5 mg/ml in 60% (v/v) ethanol. Highly
immunogenic peptides derived from a2-gliadin (LQLQPF-
PQPQLPYPQPQLPYPQPQLPYPQPQPF; 33-mer) [17] or c-
gliadin (FLQPQQPFPQQPQQPYPQQPQQPFPQ; 26-mer) [18]
were chemically synthesized at a purity of 95% (21st Century
Biochemicals, Marlboro, MA). Both peptides were dissolved in
milliQ water at 10 mg/ml, and their concentration was verified by
measurement of the OD at 215 nm applying a specific absorption
coefficient e=20. The mixture of gliadins, the 33-mer or the 26-
mer were added to a suspension of dental plaque bacteria in saliva
ion buffer (OD620 1.2) or to WS to final concentrations of
250 mg/ml. After various incubation time intervals, 100 ml aliquots
were removed and boiled to inactivate enzyme activity. The
100 ml gliadin-containing sample aliquots were analyzed by SDS-
PAGE. The 33-mer/26-mer-containing sample aliquots were
subjected to RP-HPLC.
SDS PAGE
To the gliadin degradation sample aliquots, EDTA was added to
a final concentration of 2.5 mM. Samples were dried using a speed-
vac (Savant, Thermo Electron, Waltham, MA) and suspended in
SDS sample buffer containing 0.4 mM EDTA, 2% (w/v) sodium
dodecyl sulfate (SDS), 278 mM Tris/HCl (pH=8.5), 292 mM
sucrose, 0.075% Serva Blue G250 (w/v) and 0.025% Phenol Red
(w/v). Samples were loaded onto pre-cast 12% gels (Novex,
InVitrogen, Carlsbad, CA). Running buffer contained 50 mM 2-
(N-morpholino) ethane sulfonic acid (MES), 50 mM Tris base
(pH=7.3), 0.1% (w/v) SDS. Electrophoresis was carried out at a
constant voltage of 120 V. Gels were stained for 24 h with 0.1%
Coomassie brilliant blue in 40% (v/v) methanol and 10% (v/v)
acetic and destained in the same solution without dye.
Reversed-Phase High Performance Liquid
Chromatography (RP-HPLC)
To the incubation sample aliquots containing the 33-mer or the
26-mer, 900 ml 0.1% (v/v) trifluoroacetic acid (TFA) was added
followed by filtration of the sample over a 0.22 mm filter (Pall
Cooperation, Ann Arbor, MI). RP-HPLC of the samples was
carried out using a HPLC Model 715 (Gilson, Middleton, WI) and
a C-18 column (TSK-GEL 5 mm, ODS-120T, 4.66250 mm,
TOSOHaas, Montgomeryville, PA). The 33-mer, 26-mer and
fragments thereof were eluted using a linear gradient from 0% to
55% buffer B containing 80% (v/v) acetonitrile and 0.1% (v/v)
TFA over a 75 min time interval at a flow rate of 1.0 ml/min [19].
The eluate was monitored at 219 and 230 nm and eluting
fractions were collected using peak width and peak sensitivity
settings of 1.2 and 5, respectively (Unipoint version 3.3, Gilson).
Liquid Chromatography Electrospray Ionization Tandem
Mass Spectrometry (LC-ESI-MS/MS)
Mass spectrometry was conducted using a capillary nano-flow
liquid chromatography and electrospray ionization tandem mass
spectrometer (LC-ESI-MS/MS). HPLC fractions containing
individual gliadin degradation peptides were concentrated under
vacuum, suspended in 5% acetonitrile in 0.1% formic acid, and 1–
3 ml samples were injected using an autosampler (Micro AS,
Thermo Finnigan, San Jose, CA). Separation/elution of peptides
was achieved using an in-line capillary C-18 column (Magic C-18,
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Micron Bioresource) applying a gradient from 5 to 95%
acetonitrile in 0.1% formic acid over a 35 min time interval at a
flow rate of 250 nl/min. Micro-LC separation generated the total
ion (base peak) chromatogram in a survey scan with an m/z range
from 400–2000. This was followed by the sequential selection of
five peptide ions for collision induced dissociation in descending
order of signal intensity. The process incorporated a ‘‘dynamic
exclusion’’ step of abundant peptide ions allowing also the
detection of lower abundance peptide ions within the total ion
chromatogram.
The rawMS data of the mixture of gliadins were searched against
a total gluten/gliadin database which was downloaded from http://
appliedbioinformatics.wur.nl/. The database contained 618 gliadin
and glutenin-derived protein entries from Triticum aestivium (wheat).
The rawMS data of the fragments from the 33-mer and the 26-mer
were searched against an in-house generated database containing
just these two peptides. The MS/MS spectra obtained were
searched using SEQUEST software (Bioworks Browser 3.3.1,
Thermo-Finnigan). The SEQUEST X-corr values applied for
non-tryptic peptides were as reported previously [20] and the DCn
value was set at.0.1. Each search result was furthermore validated
by manual inspection of the acquiredMS/MS spectra to ensure that
the fragment ions (e.g. b and y ions) were above background level
and that three consecutive b- and y-ions we found for each identified
peptide. Due to the highly repetitive nature of sequences within the
gliadin structure and the limited variety of amino acids, data could
not be searched against reversed gluten/gliadin databases as a
decoy. Rather, a stringent peptide probability setting of 0.05 was
applied. To establish the suitability of the selected setting to avoid
false positive identifications, MS/MS data of a digest of the 33-mer
were searched against an all gluten database. This yielded only the
identification of bona fide peptides contained within the 33-mer (data
not shown).
pH activity profile of gliadin-degrading enzymes
Dental plaque bacteria suspended in 2 ml milliQ water were
sonicated using a Branson Sonifier 450 at an output setting of 5 (30
Watts). The sample was sonicated for 30 cycles of 10 seconds each
and was chilled on ice to prevent temperature increase and
protease inactivation. The supernatant was harvested by centri-
fugation for 2 min at 10,0006 g, aliquoted into 8 equal portions
and concentrated to,20 ul using a speedvac (Savant). Each of the
fractions was subjected to gliadin zymography (see details below).
After electrophoresis and renaturing of the gel, the 8 gel lanes were
separated with a razor blade and developed in 20 mM TrisBase/
TrisHCl solutions adjusted to pH 3, 4, 5, 6, 7, 8, 9 or 10,
respectively.
Liquid iso-electric focusing (IEF) of gliadin-degrading
enzymes
A concentrated suspension of plaque bacteria in 2 ml milliQ
water was sonicated as described above. The sample was
centrifuged for 2 min at 10,0006g and the supernatant was diluted
with water to a final volume of 3 ml (S1). The protein concentration
in S1 was determined at 215 nm (e=20). A 300 ml aliquot of S1 was
set aside. To the remainder of the solution, a mixture of ampholytes
(Bio-lyte 3/10, Bio-Rad, Hercules, CA) were added to a final
concentration of 5% (v/v) (S2). The electrode assemblies of a
MicroRotofor focusing chamber (Bio-Rad) were filled with 0.1 M
phosphoric acid (anode electrolyte) and 0.1 M sodium hydroxide
(cathode electrolyte). S2 was applied to the separating chamber
using a syringe and native liquid IEF was performed at 4uC at 1 W
applying a gradual increase in voltage from 50 V to 320 V over a
2 h time span. Ten 200 ml fractions (F1–F10) containing plaque
supernatant proteins separated based on iso-electric point were
harvested in a tray under vacuum according to the manufacturer’s
instructions. The pH value of each fraction was determined using
pH strips. S1 and F1-F10 were subsequently concentrated to
,20 ul using a speed-vac (Savant), and analyzed for protease
activity by gliadin zymography.
Gliadin zymography
Samples to be analyzed were suspended in sample buffer
containing 0.25 M Tris/HCl, 10% glycerol, 2% SDS and
0.0025% bromophenol blue. The separating gel contained
375 mM Tris/HCl (pH 8.8), 8% acryl/bisacrylamide (19:1 ratio),
0.1% (w/v) SDS, 2 mg/ml gliadin, 0.05% (w/v) ammonium
persulfate (APS) and 0.04% (v/v) TEMED. The stacking gel
contained 126 mM TrisHCl (pH 6.8), 4% acryl/bisacrylamide
(19:1), 0.1% (w/v) SDS, 0.05% (w/v) APS and 0.1% (v/v)
TEMED. The running buffer contained 24 mM TrisBase,
192 mM glycine and 0.1% (w/v) SDS (pH 8.3). Electrophoresis
was carried out at a constant voltage of 100 V at 4uC. Gels were
renatured by washing for 2630 min at 22uC in zymogram
renaturing buffer followed by washing for 2620 min in zymogram
developing buffer (both obtained from InVitrogen) and incubation
in the same buffer for 48 h. Gels were stained in 40% methanol/
10%acetic acid/0.1% Coomassie brilliant blue R-250 and
destained in the same solution without dye.
Alignment of gliadin epitopes with basic PRPs
Sequences of 10 T-cell stimulatory peptides [21] were aligned
with basic PRP1, 2, 3, and 4 using the Sim alignment tool at the
ExPASy proteomics server and ClustalX software (Version 2.0.12)
applying the following parameters: comparison matrix: BLO-
SUM62; gap open penalty: 12; gap extension penalty: 4.
Results
Structural similarities between gliadins and basic PRPs
The recent discovery of an oral glutamine endoprotease cleaving
basic PRPs prompted us to study their capability to cleave
immunogenic epitopes of gliadins which drive intestinal inflamma-
tion in celiac disease. When the primary amino acid sequences of
gliadins and basic PRPs were compared, both protein families were
found to share interesting structural features. First, gliadins and
basic PRPs are very similar in size, averaging 307 and 357 amino
acids (including signal peptides), respectively. Second, in gliadins as
well as basic PRPs the amino acids glutamine (Q) and proline (P)
combined account for about 50% of the total amino acid
composition (Table 1). A noticeable difference though is that the
relative proportion of glutamine and prolines in gliadins and basic
PRPs is reversed. Third, the XPQ sequence, prevalent in basic
PRPs is also frequently occurring in gliadins. An example of a
comparison between the amino acid sequences of a basic PRP2 and
v-5 gliadin is shown in Table 2. In some gliadins such as v-5
gliadin, the XPQ tripeptide is present at an exceptionally high
frequency, even exceeding that observed in basic PRBs (Table 1).
Hydrolysis of gliadin-derived synthetic enzyme
substrates
The KPQ tripeptide is abundant in salivary basic proline-rich
proteins and cleaved effectively [14]. While KPQ is not present in
gliadins, YPQ is a relatively abundant tripeptide, especially in the
immunogenic 33-mer peptide. To study oral microbial enzyme
specificities directed at gliadins, we synthesized Z-YPQ-pNA, as
well as three other gliadin-derived tripeptide analogs, Z-QQP-pNA,
Z-PPF-pNA and Z-PFP-pNA with Z representing benzyloxycarbo-
Oral Microbes Degrading Gluten
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nyl (protective group) and pNA representing paranitroanilide
(reporter group). The substrates were incubated with a suspension
of plaque bacteria and hydrolysis was monitored spectrophotomet-
rically. Among the four substrates, Z-YPQ-pNAwas most efficiently
cleaved by enzymes contained in dental plaque (Figure 1A).
However, all four substrates were hydrolyzed at extended
incubation times (Figure 1B). No cleavage was noted when
substrates were incubated in saliva ion buffer only (Figure 1C),
even negative values were observed which can be explained by
resolution of minor precipitates as the incubation time progressed.
Likewise, no substrate hydrolysis was observed in the presence of
trypsin (data not shown). The diverse cleavage specificities
associated with plaque bacteria suggests the presence of multiple
proteolytic enzymes capable of targeting dietary gliadins.
Degradation of gliadins
To investigate if gliadins were cleaved by oral microbial
proteases, a commercial preparation of a mixture of all gliadins
was used, containing a variety of a/b-, v- and c-gliadins. Gliadins
stain poorly with coomassie and appeared as major bands in the
,35–47 kD region (Figure 2, lane 4). Other minor components,
including traces of albumins, globulins and glutenins, may also be
present but were likely low in content. Our studies focused on the
protease sensitivity of the ,35–47 kD protein bands. Figure 2
shows that after ,6 h incubation with plaque bacteria the 35–
47 kD bands had undergone substantial degradation and were
virtually undetectable after 24 h incubation whereas gliadins were
stable in saliva ion buffer only.
Proteolysis of synthetic gliadin peptides (33-mer and
26-mer)
Within the gliadin sequences, certain peptide regions are
particularly immunogenic and resistant to degradation by
human-derived digestive enzymes. These are a 33-mer peptide
present in a2-gliadin, also denoted as ‘‘superantigen’’ [13,17,22],
and a 26-mer domain derived from c-gliadin[18]. The suscepti-
bility of these peptides to proteolytic breakdown by oral microbial
enzymes was investigated by RP-HPLC. The intact 33-mer
peptide at the applied gradient eluted after 66 min (Figure 3A).
We confirmed that both peptides are resistant to digestion by the
major human digestive enzymes trypsin, chymotrypsin and pepsin
after 24 h of incubation (data not shown). In a suspension of
plaque bacteria, however, the 33-mer completely degraded after
5 h of incubation, as evidenced by disappearance of the peak at
66 min and appearance of degradation fragments eluting between
60–66 minutes and between 25 and 30 minutes. The 26-mer was
also cleaved by dental plaque bacteria (Figure 3C), yielding
fragments eluting between 25 and 30 minutes and between 35
minutes and 52 minutes. No degradation of the 33-mer and the
26-mer was observed when incubations were carried out in saliva
ion buffer alone (Figures 3B and 3D, respectively), indicating that
the peptides were stable unless oral bacterial enzymes were present
in the incubation mixture.
In addition we investigated if protease activities are detectable in
human WS. WS contains about 108 oral microorganisms per ml
and is continuously swallowed reaching more downstream regions
of the gastro-intestinal tract. Data showed that the 33-mer was
proteolytically cleaved in WS from all eight healthy human
subjects examined, but substantial variation in activities was
noticeable between subjects (Figure 4).
Table 1. Characteristics of gliadins from Triticum aestivum
and human salivary basic proline-rich proteins.1
Protein # a.aa %Q %P %(Q+P) #XPQ
a/b-gliadins 288b 34 15 49 7–22
c-gliadins 276c 31 16 47 2–38
v-gliadins 356d 24 19 43 8–72
PRB1 392 16 37 53 47
PRB2 416 15 37 52 50
PRB3 309 14 35 49 20
PRB4 310 14 34 48 21
aIncluding signal peptides.
b,c,dAverage number of amino acids in a/b-gliadins (58 entries),
c-gliadins (110 entries), v-gliadins (8 entries).
doi:10.1371/journal.pone.0013264.t001
Table 2. Comparison of amino acid sequences of salivary basic proline-rich protein 2 (PRB2) from human saliva and wheat
omega-5 protein from Triticum aestivum.*
.sp|P02812|PRB2_HUMAN Basic salivary proline-rich protein 2 OS=Homo sapiens GN=PRB2 PE=1 SV=3
MLLILLSVALLALSSAQNLNEDVSQEESPSLIAGNPQGAPPQGGNKPQGPPSPPGKPQGP
PPQGGNQPQGPPPPPGKPQGPPPQGGNKPQGPPPPGKPQGPPPQGDKSRSPRSPPGKPQG
PPPQGGNQPQGPPPPPGKPQGPPPQGGNKPQGPPPPGKPQGPPPQGDNKSRSSRSPPGKP
QGPPPQGGNQPQGPPPPPGKPQGPPPQGGNKPQGPPPPGKPQGPPPQGDNKSQSARSPPG
KPQGPPPQGGNQPQGPPPPPGKPQGPPPQGGNKSQGPPPPGKPQGPPPQGGSKSRSSRSP
PGKPQGPPPQGGNQPQGPPPPPGKPQGPPPQGGNKPQGPPPPGKPQGPPPQGGSKSRSAR
SPPGKPQGPPQQEGNNPQGPPPPAGGNPQQPQAPPAGQPQGPPRPPQGGRPSRPPQ
.tr|Q402I5|Q402I5_WHEAT Omega-5 gliadin OS=Triticum aestivum PE=4 SV=1
MKTFIIFVLLAMAMNIASASRLLSPRGKELHTPQEQFPQQQQFPQPQQFPQQQIPQQHQI
PQQPQQFPQQQQFLQQQQIPQQQIPQQHQIPQQPQQFPQQQQFPQQHQSPQQQFPQQQFP
QQKLPQQEFPQQQISQQPQQLPQQQQIPQQPQQFLQQQQFPQQQPPQQHQFPQQQLPQQQ
QIPQQQQIPQQPQQIPQQQQIPQQPQQFPQQQFPQQQFPQQQFPQQEFPQQQQFPQQQIA
RQPQQLPQQQQIPQQPQQFPQQQQFPQQQSPQQQQFPQQQFPQQQQLPQKQFPQPQQIPQ
QQQIPQQPQQFPQQQFPQQQQFPQQQEFPQQQFPQQQFHQQQLPQQQFPQQQFPQQQFPQ
QQQFPQQQQLTQQQFPRPQQSPEQQQFPQQQFPQQPPQQFPQQQFPIPYPPQQSEEPSPY
QQYPQQQPSGSDVISISGL
*XPQ sequences are underlined.
doi:10.1371/journal.pone.0013264.t002
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LC-ESI-MS/MS of fragments from the 33-mer and 26-mer
In order to anticipate if oral microbial enzymes could cleave and
theoretically neutralize the immunogenic epitopes contained within
the 33-mer 26-mer sequences, the cleavage products of both
peptides were structurally characterized by LC-ESI-MS/MS. The
RP-HPLC fractions collected for this purpose are indicated with
horizontal bars in Figures 3A and 3C. The fragments generated
from the 33-mer and the 26-mer are presented in supplemental
Figure S1. Short N- and C-terminal peptides (,7 amino acids) were
not detected, since these eluded detection by LC-ESI-MS/MS for
technical reasons. The peptides identified with high confidence
show that virtually all sites are targeted in both the 33-mer and the
26-mer. The diversity of peptides generated in mixed dental plaque
is reflective of the multitude of enzymatic activities that can be found
in this biofilm. Dental plaque furthermore likely contains exopep-
tidases that could have contributed to the pattern observed. While
proteolysis did not abolish all immunogenic epitopes in the time
span examined, the results together with hydrolysis of -pNA
derivatized substrates indicate that the gliadins are excellent
substrates for oral microbial enzymes.
pH activity profile of oral gliadin-degrading enzymes
In view of the varying pH conditions along the gastro-intestinal
tract, the pH activity profile of the oral gliadin-degrading enzymes
was investigated. For this purpose plaque was sonicated which
released the enzymes into the supernatant. The supernatant
Figure 1. Hydrolysis of gliadin-derived enzymatic substrates. Dental plaque was suspended in saliva ion buffer to an OD620 of 1.2. Substrates
Z-YPQ-pNA, Z-QQP-pNA, Z-PPF-pNA and Z-PFP-pNA were added to final concentrations of 200 mM. Substrate conversion was monitored
spectrophotometrically at 405 nm. A, hydrolysis measured during the 0–6 hr time interval; B, hydrolysis measured after 6 h, 24 h and 48 h; C,
substrates incubated for 48 h in saliva ion buffer only (control).
doi:10.1371/journal.pone.0013264.g001
Figure 2. Degradation of a mixture of gliadins (G) by oral plaque microorganisms. Dental plaque was suspended in saliva ion buffer to an
OD620 of 1.2. Gliadin (Sigma) was added to a final concentration of 250 mg/ml. After various incubation times at 37uC 100 ml aliquots were removed,
boiled and analyzed by SDS PAGE. A, lane 1, Molecular weight standard; lane 2: plaque bacterial suspension only (t = 0); lane 3: plaque suspension +
gliadin (t = 0); lane 4: 25 mg gliadin (t = 0); B, lanes 5 to 10: plaque suspension + gliadin, sampled after t = 0, t = 2 h, t = 4 h, t = 6 h, t = 24 h and t = 48 h,
respectively. C, gliadin incubated for the same time intervals in saliva buffer only (control).
doi:10.1371/journal.pone.0013264.g002
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fraction was subjected to gliadin zymography and developed in
buffers with pH values ranging from 3 to 10 (Figure 5A). The
major activity in the sonicate supernatant was associated with a
band with an Mr ,70 kD. Gliadin degradation was observed in
gel strips that were developed in buffers with pH values from 4 to
10 with optimal gliadin-degrading activity at pH 8–10. Weak
activity was observed at pH=3. Activity at this pH was confirmed
with the synthetic substrate Z-YPQ-pNA (Figure 5B). However, at
pH=2 no activity could be demonstrated.
Overall iso-electric points of oral gliadin-degrading
enzymes
The pH activity experiment provided a first assessment of the
overall molecular weights - and pH dependence- of the major
proteolytic components in dental plaque. To investigate additional
physicochemical properties of the enzymes of interest, we
subjected the plaque supernatant protein mixture to liquid iso-
electric focusing (IEF). The pH of the ten fractions collected
ranged from 2.5 to 10. Protease activities in each of the fractions
were then examined by gliadin zymography (Figure 6). Most of the
proteases had migrated to the anode and appeared in fractions
with pH values of 3–4. In the most acidic fraction (pH 2.5) a high
molecular weight protease of Mr ,140 kD was observed. In the
pH 3.0 fraction enzymes with strong activity were noted of
,70 kD as well as enzymes with higher Mr values, perhaps
representing multimeric variants of the 70 kD enzyme. At pH 4.0
various enzymatic bands were observed in the same 70 kD Mr
region. Weak protease activities of ,65–70 kD were noted in
fractions with pH values of 5, 6, and 7, and weak activities
associated with higher Mr species (.150 kD) were discernable in
fractions exhibiting alkaline pH values. Overall, the results
indicate that the most prominent gliadin-degrading enzymes in
the oral cavity are acidic in nature.
Discussion
Between ,0.5 and 2% of a major part of the human population
has more or less severe forms of celiac disease [13]. Most of those
diagnosed profit from a strict life-long gluten free diet which is
extremely difficult to maintain, especially since even minor gluten
contamination in foods which are omnipresent needs to be ruled
Figure 3. Degradation of gliadin-derived peptides by dental plaque bacteria. The 33-mer or the 26-mer were added to a final
concentration of 250 mg/ml to a suspension of dental plaque bacteria in saliva ion buffer (OD620 1.2). After t = 0 h, 2 h and 5 h, 100 ml aliquots were
removed, boiled and subjected to RP-HPLC. A and C, chromatograms of the 33-mer and 26-mer peptides incubated in dental plaque suspension; B
and D, 33-mer and 26-mer peptides incubated in saliva ion buffer only (control).
doi:10.1371/journal.pone.0013264.g003
Figure 4. Degradation of the 33-mer in human whole saliva
(WS). The 33-mer was added to a final concentration of 250 mg/ml to
WS collected from eight individual subjects. In each of the saliva
samples, the degradation of the 33-mer was monitored. The average
peak area and standard deviation of the 33-mer incubated for 0 h, 2 h,
5 h, 8 h and 24 h in the eight WS samples are shown. Control: 33-mer
only, incubated in saliva ion buffer for the same time intervals.
doi:10.1371/journal.pone.0013264.g004
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out [23]. One of the therapeutic strategies to counteract or prevent
the deleterious effect of these minor amounts of dietary gluten
focuses on proteolytic enzymes to aid in their degradation, thus
preventing their antigenic presentation to and activation of
intestinal T cells [24,25]. The results presented in this manuscript
indicate that unexpectedly such potent digestive enzymes are
naturally associated with the upper GI tract, i.e., the oral cavity.
Our studies on oral microbial proteases showed that: 1) the
tripeptide YPQ which frequently occurs in gluten is preferentially
targeted; 2) gliadin as well as two otherwise highly immunogenic
and protease-resistant gliadin peptides are proteolytically degrad-
ed; 3) gliadin-degrading enzymes are active over a wide pH range
(pH 3–10); and 4) most of the oral gliadin-degrading enzymes are
acidic in nature, exhibiting IEP values of 2.5 to 4. The data
presented suggest a potential role for the oral microbiome in
gluten digestion. Furthermore, given the broad pH activity range
and partial species overlap between oral, oesophageal and
duodenal GI microbiomes, it is likely that gliadin-degrading
activities extend well beyond the oral region.
While novel with respect to source, gliadin degrading enzymes
have been discovered in nature and are being exploited for their
potential therapeutic application as dietary supplements in celiac
disease. One of the enzymes that is being considered for this purpose
is EP-B2 which is a glutamine endoprotease produced from
germinating wheat [10]. Another group of enzymes capable of
cleaving gluten are the prolyl endoproteases (PEP), specifically, PEP
from Aspergillus niger (AN-PEP) [26] and PEP from Sphingomonas
capsulata (SC-PEP) [27]. EP-B2, AN-PEP and SC-PEP have been
studied as food additives, either alone or in combination [28] and
are in clinical phase I and IIa trials (Clinicaltrails.gov identifiers
NCT00810654 and NCT00959114). An important difference
between these enzymes and those found in the GI tract is the fact
that the former enzymes originate from non-human associated
sources, i.e. non-resident bacteria or plants. Resident gluten-
degrading microorganisms described in the present manuscript
are a viable source of novel enzyme(s) and offer the additional
advantage to be potentially exploited as probiotic agents to generate
more long lasting changes in GI gluten digestive capacity.
Figure 5. Determination of the pH activity profile of oral gliadin-degrading enzymes. A, Gliadin zymography. Sonicated plaque bacterial
supernatant was aliquoted into eight equal fractions. Each fraction containing 90 mg protein was loaded onto a gliadin zymogram gel. After
electrophoresis and renaturing the gel was cut and individual lanes were developed in 20 mM Tris buffers exhibiting pH values from 3 to 10. Far left
lane: molecular weight standard. B, Z-YPQ-hydrolysis. Plaque bacteria were suspended 20 mM Tris buffers varying in pH from 2 to 10 to a final OD620
of 1.2. Suspensions were mixed with Z-YPQ-pNA (200 mM). Substrate hydrolysis was monitored spectrophotometrically at 405 nm. A representative
graph of 3 independent experiments is shown.
doi:10.1371/journal.pone.0013264.g005
Figure 6. Isoelectric focusing profile of the gliadin degrading enzymes. Proteins in sonicated plaque bacteria supernatant were separated
based on isoelectric point by liquid iso-electric focusing (IEF). The enzymatic activity in each of the 10 IEF fractions was established by gliadin
zymography. Far left lane, MW standard; S1: plaque supernatant sample before IEF.
doi:10.1371/journal.pone.0013264.g006
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For the reasons pointed out above it will be of high interest to
obtain the individual enzymes originating from oral bacterial
sources that are cleaving gliadin. Human saliva contains .600
different microbial strains and careful selection strategies need to
be applied to identify the most active organism(s). Studies in our
laboratory are underway to identify and characterize which
microorganisms in this microbial mixture exhibit gliadin degrad-
ing capacities. We have already identified four bacterial strains
with cleavage activities far exceeding those of the mixture of
bacteria that can be found in dental plaque (manuscript in
preparation). Identification of such bacteria is a first step towards
the isolation, cloning and full characterization of the gliadin-
degrading enzymes, and subsequent evaluation of these enzymes
in in vitro and in vivo gliadin detoxification assays.
Human saliva-derived basic PRPs and wheat-derived gliadins
show noticeable similarities in their amino acid composition with
proline and glutamine being the chief constituent amino acids. Since
gliadins contain well defined T-cell stimulatory domains for patients
carrying HLA-DQ2 or HLA–DQ8 [21,29,30] we studied to what
extent these gliadin domains show structural overlap with salivary
basic PRPs. While it would be highly unlikely that the exact
immunogenic domains stimulating T cell in patients with celiac
disease are present in basic PRPs, given the successful reversal of
celiac symptoms by gluten elimination from the diet in most
patients, it is of interest that some celiac patients are refractory to a
gluten-free diet [31]. The major basic salivary proline-rich proteins
are encoded by PRB1, PRB2, PRB3 and PRB4 and contain multiple
repeat domains of 20 or 21 amino acids [32] (supplemental Figure
S2). The alignment of gliadin epitopes [33] with selected regions in
the basic PRP sequences is depicted in supplemental Figure S3. The
comparison revealed that gliadin epitopes are up to 50%
homologous with basic PRP sequences. Due to the repeat domain
structures in basic PRPs the gliadin-like domains are in some cases
present in multiple copies. While the percentage overlap is
substantial, it is evident from this analysis that no single point
mutation in a basic PRP gene would generate a classical toxic
gliadin epitope. Nevertheless, given the noted structural resem-
blances between these two protein families, and the fact that T-cell
epitopes in gliadins typically cluster in regions with a high proline
content [34], it will be of interest to characterize the salivary PRP
geno- and phenotype of celiac patients.
There must be a biological reason, perhaps a nutritional reason
that human saliva contains proteins that are so similar in composition
to dietary proteins. Both protein families enter the GI tract and come
into contact with resident GI microorganisms. Per day about 0.8 L of
saliva is produced, primarily by the major salivary glands, and
swallowed. Of note, salivary PRPs constitute approximately 70% of
all secreted salivary proteins [35]. With an average WS protein
concentration of 2 mg/ml of protein, it can be estimated that about
1 g of PRPs and derived peptides enter the GI system each day. In
addition, the Western daily diet contains about 10–20 g of gluten
proteins, which are cleaved in part and incompletely by human
digestive enzymes and, as we hypothesize, are further fragmented by
GI microbial proteases. The high numbers of proline/glutamine
containing peptides from different sources continuously entering the
gastro-intestinal lumen is an intriguing notion. In addition, glutamine
endoprotease-producing microorganisms are also constantly being
swallowed with saliva. It may be speculated that proline/glutamine
peptide profiles and/or GI microbial glutamine endoprotease
activities show differences between healthy and celiac patients, which
could be important clinically.
Finally, our results lay the foundation for a further character-
ization of the oral bacteria that secrete gliadin (gluten) degrading
enzymes as well as identification and purification of their most
active gliadin-cleaving enzymes. Apart from interesting biological
findings, these bacteria and enzymes may lead to novel and
effective strategies to detoxify immunogenic gluten peptides prior
to reaching the proximal small intestine.
Supporting Information
Figure S1 Fragmentation of gliadin 33-mer and 26-mer by oral
microbial enzymes in dental plaque. The 33-mer and the 26-mer
were added to plaque suspension in saliva ion buffer (OD620 1.2)
to a final concentration of 250 mg/ml and incubated for 5 h.
Samples were analyzed by RP-HPLC, degradation fragments
were collected and subjected to LC-ESI-MS/MS. The peptides
identified in the individual RP-HPLC fractions were combined.
Found at: doi:10.1371/journal.pone.0013264.s001 (4.23 MB TIF)
Figure S2 Schematic presentation of the structures of human
salivary basic proline-rich proteins. White boxed areas: signal
peptides; dark grey boxed areas: non-repeat domains; light grey
boxed areas: repeat domains. The consensus amino acid sequences
of the repeat domains are indicated. In PRB1L and PRB2L some
of the repeat domains are interspaced with single proline (P) or
serine (S) residues. Open circles: repeat regions missing in the
truncated M-allelic isoforms; diamonds: repeat regions missing in
the truncated S-allelic isoforms. Note in PRB4 that the missing
segments in the M and S isoforms overlap only in part with the
repeat domains.
Found at: doi:10.1371/journal.pone.0013264.s002 (0.21 MB TIF)
Figure S3 Sequence similarities between salivary basic proline-rich
proteins and immunotoxic gliadin epitopes. Displayed are selected
regions within the basic PRP structures (top sequences, bolded) and
gliadin epitopes (underneath). The amino acids that are homologous
in the compared sequences are indicated with an asterisk.
Found at: doi:10.1371/journal.pone.0013264.s003 (4.23 MB TIF)
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